 |
Whole Genome Sequencing in Type 2 Diabetes Genetic Study
May 9, 2012
|
11.9 KB |
|
| |
MOUNTAIN VIEW, Calif., May 9, 2012 (GLOBE NEWSWIRE) -- Complete Genomics Inc. (Nasdaq:GNOM) announced today that it has sequenced the genomes of 600 individuals from 20 Mexican-American families from San Antonio in what is thought to be the largest whole genome sequencing family study conducted to date and the first such study of its kind in a Lati...
|
|
Complete Genomics Builds Asia-Pacific Presence, Signs Distributor Agreements in Australia, China, Japan and Korea
May 8, 2012
|
11.3 KB |
|
| |
MOUNTAIN VIEW, Calif., May 8, 2012 (GLOBE NEWSWIRE) -- Complete Genomics Inc. (Nasdaq:GNOM), the whole human genome sequencing company, today announced that it has signed four new distributor agreements with well-established Asia-Pacific life sciences companies — GeneWorks Pty Ltd. In Australia, Cyagen Biosciences in China, AR Brown Co. Ltd. ...
|
|
Complete Genomics Reports First Quarter 2012 Results
May 7, 2012
|
17.0 KB |
|
| |
MOUNTAIN VIEW, Calif., May 7, 2012 (GLOBE NEWSWIRE) -- Complete Genomics, Inc. (Nasdaq:GNOM), the whole human genome sequencing company, today announced financial results for its quarter ended March 31, 2012.First Quarter 2012 Results
We delivered data for approximately 1,200 genomes, including more than 100 non-revenue generating genomes unde...
|
|
Complete Genomics Schedules First Quarter 2012 Earnings Release and Announces Conference Call
May 3, 2012
|
8.9 KB |
|
| |
MOUNTAIN VIEW, Calif., May 3, 2012 (GLOBE NEWSWIRE) -- Complete Genomics, Inc. (Nasdaq:GNOM) will release its first quarter 2012 financial results at approximately 1:00 p.m. PDT on May 7, 2012. Dr. Clifford A. Reid, chairman, president, and CEO, and Ajay Bansal, CFO, will host a conference call on May 7, 2012 at 2:00 p.m. PDT (5:00 p.m. EDT) to dis...
|
|
Complete Genomics Now Accepts DNA Obtained From Saliva for Whole Human Genome Sequencing
Mar 29, 2012
|
10.8 KB |
|
| |
MOUNTAIN VIEW, Calif., March 29, 2012 (GLOBE NEWSWIRE) -- Complete Genomics Inc. (Nasdaq:GNOM) has begun accepting DNA samples derived from human saliva. By providing the same high-quality results for saliva-derived DNA as for samples collected from blood and cell lines, this new offering opens Complete's whole human genome sequencing service to re...
|
|
Complete Genomics Reports Fourth Quarter and Fiscal Year 2011 Results
Mar 8, 2012
|
20.1 KB |
|
| |
MOUNTAIN VIEW, Calif., March 8, 2012 (GLOBE NEWSWIRE) -- Complete Genomics, Inc. (Nasdaq:GNOM), the whole human genome sequencing company, today announced financial results for the fourth quarter and fiscal year ended December 31, 2011.Fiscal Year 2011 Results
We recognized revenue with respect to approximately 3,000 genomes, compared to appro...
|
|
Complete Genomics Schedules Fourth Quarter and Fiscal Year 2011 Earnings Release and Announces Conference Call
Mar 5, 2012
|
8.9 KB |
|
| |
MOUNTAIN VIEW, Calif., March 5, 2012 (GLOBE NEWSWIRE) -- Complete Genomics, Inc. (Nasdaq:GNOM) will release its fourth quarter and fiscal year 2011 financial results after markets close on March 8, 2012. Dr. Clifford A. Reid, chairman, president, and CEO, and Ajay Bansal, CFO, will host a conference call on March 8, 2012 at 1:30 p.m. PST (4:30 p.m....
|
|
Complete Genomics to Present at Two Upcoming Investor Conferences
Mar 2, 2012
|
9.0 KB |
|
| |
MOUNTAIN VIEW, Calif., March 2, 2012 (GLOBE NEWSWIRE) -- Complete Genomics (Nasdaq:GNOM) today announced that members of its management team will present at the following conferences in March:
Ajay Bansal, CFO of Complete Genomics, will present at the Cowen and Company 32nd Annual Health Care Conference on Wednesday, March 7, at 10:40 a.m. ET ...
|
|
Complete Genomics Announces Formation of Genomic Medicine Advisory Board
Feb 29, 2012
|
13.7 KB |
|
| |
MOUNTAIN VIEW, Calif., Feb. 29, 2012 (GLOBE NEWSWIRE) -- Complete Genomics Inc. (Nasdaq:GNOM), the whole human genome sequencing company, today announced the formation of its Genomic Medicine Advisory Board (GMAB). The GMAB will provide insight and guidance on the best ways for the company to provide sequencing services to healthcare organizations ...
|
|
Study Published in Journal Nature Suggests New Genomic Pathways for Neuroblastoma
Feb 24, 2012
|
13.4 KB |
|
| |
MOUNTAIN VIEW, Calif., Feb. 24, 2012 (GLOBE NEWSWIRE) -- Complete Genomics, Inc. (Nasdaq:GNOM) announced today that the journal Nature has published a neuroblastoma study conducted using the company's high-depth whole human genome sequencing service. The company believes that this is not only the most comprehensive genomic analysis of neuroblastoma...
|
|
Complete Genomics Co-Authors Paper Demonstrating Impact of Hepatitis B Virus on Liver Cancer Genomes
Feb 23, 2012
|
14.8 KB |
|
| |
MOUNTAIN VIEW, Calif., Feb. 23, 2012 (GLOBE NEWSWIRE) -- Complete Genomics Inc. (Nasdaq:GNOM) announced today that Genome Research has published a paper it co-authored describing the effects of hepatitis B virus (HBV) integration into the genomes of liver cancer patients. HBV infection is a recognized risk factor for the development of liver cancer...
|
|
Complete Genomics Named to MIT's Technology Review Top 50 Innovative Companies List for Third-Consecutive Year
Feb 21, 2012
|
12.5 KB |
|
| |
MOUNTAIN VIEW, Calif., Feb. 21, 2012 (GLOBE NEWSWIRE) -- Complete Genomics Inc. (Nasdaq:GNOM) today announced that the company will be included in MIT's Technology Review TR50, an annual list of the 50 most innovative technology companies in the world. It is the third-consecutive year that Complete Genomics has been named to the list.
Companies...
|
|
Complete Genomics Launches Genomic Discovery Software Partners Program
Feb 16, 2012
|
14.7 KB |
|
| |
MOUNTAIN VIEW, Calif., Feb. 16, 2012 (GLOBE NEWSWIRE) -- Complete Genomics Inc. (Nasdaq:GNOM - News), the whole human genome sequencing company, today introduced its Genomic Discovery Software Partners Program. Ingenuity® Systems, Golden Helix and DNAn...
|
|
Mayo Clinic Selects Complete Genomics to Provide Outsourced Whole Genome Sequencing
Feb 13, 2012
|
13.0 KB |
|
| |
MOUNTAIN VIEW, Calif., Feb. 13, 2012 (GLOBE NEWSWIRE) -- Complete Genomics Inc. (Nasdaq:GNOM) announced today that it has been selected by Mayo Clinic's Center for Individualized Medicine to provide outsourced whole human genome sequencing. Mayo Clinic researchers will now be able to employ Complete Genomics' sequencing service for some of its l...
|
|
Complete Genomics Publishes Paper Describing Its Informatics Approach for High-Accuracy Whole Human Genome Sequencing
Jan 19, 2012
|
16.4 KB |
|
| |
MOUNTAIN VIEW, Calif., Jan. 19, 2012 (GLOBE NEWSWIRE) -- Complete Genomics Inc. (Nasdaq:GNOM) announced today that the Journal of Computational Biology has published online the company's paper describing some of the computational methods that enable it to produce highly-accurate whole human genome sequencing data. The paper is available at http://w...
|
|
Complete Genomics Announces Shipment of Approximately 3,000 Genomes in 2011
Jan 9, 2012
|
10.9 KB |
|
| |
MOUNTAIN VIEW, Calif., Jan. 9, 2012 (GLOBE NEWSWIRE) -- Complete Genomics, Inc. (Nasdaq:GNOM) today announced that the company delivered approximately 3,000 genomes to its customers in 2011 and is entering 2012 with contracts for approximately 5,800 genomes. The company delivered more than 600 genomes to its customers in the fourth quarter of 2011....
|
|
Complete Genomics to Present at Oppenheimer Healthcare Conference
Dec 9, 2011
|
10.2 KB |
|
| |
MOUNTAIN VIEW, Calif., Dec. 9, 2011 (GLOBE NEWSWIRE) -- Complete Genomics (Nasdaq:GNOM) today announced that Ajay Bansal, Chief Financial Officer of Complete Genomics will present at the Oppenheimer 22nd Annual Healthcare Conference at 11:25 a.m. ET on Wednesday, December 14, 2011. The conference is being held at the Waldorf-Astoria Hotel in New Yo...
|
|
Complete Genomics Reports Results for Third Quarter 2011
Nov 7, 2011
|
20.7 KB |
|
| |
MOUNTAIN VIEW, Calif., Nov. 7, 2011 (GLOBE NEWSWIRE) -- Complete Genomics, Inc. (Nasdaq:GNOM), the whole human genome sequencing company, today announced its financial results for the quarter ended September 30, 2011.Third Quarter 2011 Results
The company recognized revenue for over 700 genomes compared to over 300 genomes recognized in the th...
|
|
Complete Genomics to Present at Two Upcoming Investor Conferences
Nov 3, 2011
|
10.3 KB |
|
| |
MOUNTAIN VIEW, Calif., Nov. 3, 2011 (GLOBE NEWSWIRE) -- Complete Genomics (Nasdaq:GNOM) today announced that Dr. Cliff Reid, chairman, president, and CEO of Complete Genomics will present at the following conferences in November:
The Credit Suisse Annual Healthcare Conference on Wednesday, November 9, at 4:00 p.m. MT in Phoenix, Arizona
...
|
|
Complete Genomics Schedules Third Quarter 2011 Earnings Release and Announces Conference Call
Nov 3, 2011
|
10.1 KB |
|
| |
MOUNTAIN VIEW, Calif., Nov. 3, 2011 (GLOBE NEWSWIRE) -- Complete Genomics, Inc. (Nasdaq:GNOM) will release its third quarter 2011 financial results after markets close on November 7, 2011. Dr. Clifford A. Reid, chairman, president, and CEO, and Ajay Bansal, CFO, will host a conference call on November 7, 2011 at 1:30 p.m. PST (4:30 p.m. EST) to dis...
|
|
|
delicious
Digg
Facebook
LinkedIn
Twitter
Yahoo! Buzz
